Results 51 to 60 of about 3,021 (181)

Trends in Opioid Medication Adherence During the COVID-19 Pandemic: Retrospective Cohort Study

JMIR Public Health and Surveillance, 2023
BackgroundThe recent pandemic had the potential to worsen the opioid crisis through multiple effects on patients’ lives, such as the disruption of care. In particular, good levels of adherence with respect to medication for opioid
Amir Marashi, David Warren, Gary Call, Mark Dras   +3 more
doaj   +1 more source

Interpersonal Connection and Medication for Opioid use Disorder (MOUD): Does the Endogenous Opioid System Inform the Etiology and Treatment of Addiction?

Andrea D. Clements, Tanner Clements, Mary Jo Hedrick   +2 more
openalex   +2 more sources

Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs

Substance Abuse Treatment, Prevention, and Policy, 2023
Background Medications for opioid use disorder (MOUD; methadone, buprenorphine, naltrexone) are the most effective treatments for OUD, and MOUD is protective against fatal overdoses.
Jaclyn M. W. Hughto, Abigail Tapper, Sabrina S. Rapisarda, Thomas J. Stopka, Wilson R. Palacios, Patricia Case, Joseph Silcox, Patience Moyo, Traci C. Green   +8 more
doaj   +1 more source

A conceptual framework for how structural changes in emerging acute substance use service models can reduce stigma of medications for opioid use disorder

Frontiers in Psychiatry, 2023
Stigma toward people taking medication for opioid use disorder (MOUD) is prevalent, harmful to the health and well-being of this population, and impedes MOUD treatment resource provision, help-seeking, and engagement in care.
Timothy D. Becker, Timothy D. Becker, Evan L. Eschliman, Ashish P. Thakrar, Lawrence H. Yang, Lawrence H. Yang   +5 more
doaj   +1 more source

HPR15 Comparison of Price Index Methods and Drug Price Inflation Estimates for Medications for Opioid Use Disorder (MOUD) [PDF]

Value in Health
Kenechukwu C. Ben‐Umeh, Natalie Cox, TJ Mattingly   +2 more
openalex   +2 more sources

Use and Outcomes of Medication for Opioid Use Disorder Among Patients With Opioid Use Disorder Undergoing Surgery

Annals of Surgery Open
Objective:. We examined patterns of use of perioperative medication for opioid use disorder (MOUD) in patients undergoing surgical procedures and assessed the association between MOUD use and perioperative opioid use and postsurgical adverse events ...
Alicia H. Li, MD, Yongmei Huang, MD, DrPH, Silvia S. Martins, MD, PhD, Yukio Suzuki, MD, PhD, Jennifer S. Ferris, PhD, Xiao Xu, PhD, Dawn L. Hershman, MD, Jason D. Wright, MD   +7 more
doaj   +1 more source

Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community

Addiction Science & Clinical Practice, 2022
Background Medication treatment for opioid use disorder (OUD) (MOUD; buprenorphine and methadone) reduces opioid use and overdose. Discontinuation of MOUD can quickly lead to relapse, overdose and death.
Breanne E. Biondi, Brent Vander Wyk, Esther F. Schlossberg, Albert Shaw, Sandra A. Springer   +4 more
doaj   +1 more source

Antepartum multidisciplinary approach improves postpartum pain scores in patients with opioid use disorder

Journal of Perinatal Medicine
Pregnancies affected by opioid use disorder (OUD) face difficulties with postpartum pain control. This study aims to determine if prenatal anesthesia consultation for patients on medication for opioid use disorder (MOUD) affects maternal postpartum pain ...
Yang Tiffany, Stetler Emily, Garretto Diana, Herrera Kimberly, Garry David, Heiselman Cassandra   +5 more
doaj   +1 more source

The effect of a pilot brief educational intervention on preferences regarding treatments for opioid use disorder

Drug and Alcohol Dependence Reports
Purpose: Negative perceptions around medications for opioid use disorder (MOUD) amongst the public could deter patients with opioid use disorder (OUD) from engaging with MOUD.
Emaun Irani, Colin Macleod, Stephanie Slat, Adrianne Kehne, Erin Madden, Kaitlyn Jaffe, Amy Bohnert, Pooja Lagisetty   +7 more
doaj   +1 more source

Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial

BMC Public Health, 2021
Background A key strategy for mitigating the current opioid epidemic is expanded access to medications for treating opioid use disorder (MOUD). However, interventions developed to expand MOUD access have limited ability to engage opioid users at higher ...
Dennis P. Watson, James A. Swartz, Lisa Robison-Taylor, Mary Ellen Mackesy-Amiti, Kim Erwin, Nicole Gastala, Antonio D. Jimenez, Monte D. Staton, Sarah Messmer   +8 more
doaj   +1 more source